* State budget-balancing measure leads to shift in PERA contributions
   
* Branding initiative endorsed, adopted by Board of Regents
   
* UPDATE: Flex bill clears first hurdle at Capitol
   
* Guiding principles, presidential search go back to governance groups
   
* Federal stimulus has brought $151 million to CU for research
   
* Five questions for Kerry Paterson
   
* Did you know...
   
* People
   
* Letters to the Editor
 
 NEWS FROM THE CU SYSTEM
 
  CU-BOULDER
  Stimulus grant brings $15 million to biotechnology building
 
  UCCS
  Breast cancer risk factors differ among races
 
  UC DENVER
  Successful blog creator shares experience with students
 
  ANSCHUTZ MEDICAL CAMPUS
  Some pediatric brain tumors might be worsened by immune gene expression
 
 
   Home
   Newsletter Archive
 
 
Download Newsleter in PDF
 
Share your thoughts
  LETTERS TO THE EDITOR
Share your opinions

CONTACT US
Send your thoughts and suggestions for the Newsletter
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

News from the CU system - Anschutz Medical Campus

Some pediatric brain tumors might be worsened by immune gene expression

Nicholas Foreman, M.D.
More than half of children diagnosed with ependymoma brain tumors will have them recur after standard treatment — surgery and radiation — and lead to death. University of Colorado Cancer Center researcher Nicholas Foreman, M.D., calls it "one of the most significant problems in pediatric neuro-oncology."

Foreman, director of pediatric neuro-oncology at The Children's Hospital and professor of pediatrics at the University of Colorado School of Medicine, and colleagues last year identified the reason why half of the tumors recur. He has just been awarded a $1.2 million, four-year grant from the National Cancer Institute to dig deeper into the discovery that expression of certain genes linked with immune function predicted good outcomes.

About one in 11 pediatric brain tumors are ependymomas, with about 200 new diagnoses of the disease in the United States each year. Brain tumors are the most common cause of childhood cancer death, according to the National Cancer Institute.

"As we looked closely at the tumor cells, we realized this immune expression wasn't a function of the tumor, but of the immune cells which, in some cases, were in large quantities in the tumor," Foreman said. "It turned out to be the first demonstration in any brain tumor that the immune status of the individual at diagnosis is directly related to his or her chance of being cured."

The researchers also found that certain aspects of the immune function could be blocking treatment's effectiveness, which flies against common belief that all immune reactions to a tumor are positive. Activation of macrophages, a type of immune cell, could trigger release of antibodies that work counter to treatment. These antibodies might serve both as a marker for poor outcome and a treatment target, Foreman says.

"The immune system is more complex than people had realized," he said. "Using this new grant, we hope to identify which parts of immune function is good for killing these brain tumors and which parts help keep them alive or help them grow."

Foreman's work is based on a human model of the immune system and outcomes. Most other experiments have been done in animal models, which might work differently than human systems.

In the long run, Foreman hopes the studies lead to a blood test that will tell doctors at diagnosis whether a child will have a good or poor outcome with standard treatment, and a method for manipulating patients' immune system during standard treatment to make it more effective.

The discovery was published in the Nov. 16, 2009, issue of the Journal of Immunology by Foreman and colleagues from the School of Medicine and Children's Oncology Group, a national research group. The experiments were initially done using tumor tissue samples Foreman began collecting when he arrived in Denver in 1995. The new studies will be done on tissue collected by centers across the country.

Bookmark - Print - Share

 
Previous Anschutz Medical Campus Stories

04/21/2010
School of Medicine, partners will work to prevent mistreatment of children

04/14/2010
University of Colorado Hospital provides funding for new crisis services system

04/07/2010
University of Colorado Cancer Center researchers receive $3.5 million grant

03/31/2010
Hospital receives distinguished designation for excellence in nursing

03/24/2010
Regional stem-cell center launched by School of Medicine

03/17/2010
School of Medicine program receives oral health grant

03/10/2010
UC Denver one of top places for postdocs to work

03/03/2010
University of Colorado Hospital internal medicine, specialty clinic relocating

02/24/2010
New type of complex genetic variation discovered

02/17/2010
UC Denver announces state's first bioengineering department

02/10/2010
School of Dental Medicine gives kids a smile

02/03/2010
Emergency medicine physicians take part in suicide research trial

01/27/2010
Researchers receive grant to study impact of law on public health practice

01/20/2010
Assembling planet's Tree of Life less daunting thanks to researchers

01/13/2010
State-of-the-art imaging offers enhanced treatment for arrhythmia

01/06/2010
Rural medicine, Down syndrome programs receive federal support

12/16/2009
Study highlights lack of knowledge regarding hospital medications

12/09/2009
School of Pharmacy researcher receives funding from Michael J. Fox Foundation

12/02/2009
New UC Denver program puts high school grads on pathway to med school

11/18/2009
Award of $577,000 will aid study of tuberculosis treatment

11/11/2009
Depression Center works to establish national network

11/04/2009
School of Medicine to take part in nationwide study of blood pressure

10/28/2009
College of Nursing expands offerings in Western Regional Graduate Program

10/21/2009
Study: Tanning associated with moles in very light-skinned children

10/14/2009
When the laboratory meets the studio

10/07/2009
When the laboratory meets the studio

09/30/2009
Cancer Center scientists win $870,000 ARRA Challenge Grant

09/23/2009
Cancer Center scientists win $870,000 ARRA Challenge Grant

09/16/2009
University of Colorado Cancer Center wins National Cancer Institute grant

09/02/2009
Ground broken on planned VA medical center

08/19/2009
SOM, state labor department to manage training facility

08/06/2009
Pulmonary hypertension drug helps former smokers

07/23/2009
Breast cancer researcher receives gift from Avon